Vivani to Merge Cortigent with ClearOne in Nasdaq Deal

Vivani is making a bold move to bring its wholly owned subsidiary Cortigent, Inc. onto Nasdaq — not through a traditional IPO, but by merging it directly into ClearOne, Inc. (Nasdaq: CLRO). If the deal closes, you're looking at a full rebrand: the combined company becomes Cortigent Holdings, Inc., doing business as Cortigent, and trading under the new ticker symbol "CRGT."

This is a classic reverse-merger play. Instead of the lengthy, expensive process of a standalone IPO, Cortigent gets instant public-market access by folding into an already-listed shell. For traders watching CLRO, this is the kind of structural catalyst that can move a stock hard in either direction — so pay attention to the vote timeline and any SEC filings that follow.

Read more Prediction Markets Raise Insider Trading Red Flags for Wall Street →

The name and ticker change signals Vivani's intent to make Cortigent the centerpiece going forward. ClearOne's existing business effectively takes a back seat, and the market will be repricing the stock around Cortigent's story, not ClearOne's legacy operations. That's a clean slate — and a clean trade thesis if you believe in what Cortigent is building.

For retail traders, the window between announcement and shareholder approval is historically where price discovery gets volatile. Watch for deal terms, any shareholder opposition, and regulatory sign-offs. The ticker transition from CLRO to CRGT is your confirmation signal that the merger has cleared all hurdles.

Continue reading at GlobalNewswire.